FrontView REIT, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FrontView REIT, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.12M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $15.18M | Feb 25, 2026 |
| FY2025 | Oct 2, 2024 | $44.74M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $48.27M | Mar 20, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.83M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($3.00M) | Feb 25, 2026 |
| FY2025 | Oct 2, 2024 | ($19.22M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($1.10M) | Mar 20, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.56M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($4.82M) | Feb 25, 2026 |
| FY2025 | Oct 2, 2024 | ($9.89M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($14.47M) | Mar 20, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.13M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.69M | Feb 25, 2026 |
| FY2025 | Oct 2, 2024 | $17.84M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $17.22M | Mar 20, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $854.44M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $821.81M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $772.01M | Mar 20, 2025 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $361.22M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $299.13M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $471.32M | Mar 20, 2025 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $391.20M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $324.82M | Feb 25, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($28.15M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($6.83M) | Feb 25, 2026 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.52M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $5.09M | Feb 25, 2026 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $314.25M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $266.54M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $436.45M | Mar 20, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22.11M | Feb 25, 2026 |
| FY2024 | Dec 31, 2024 | 17.29M | Mar 20, 2025 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.57M | Feb 25, 2026 |
| FY2025 | Oct 2, 2024 | $1.50M | Feb 25, 2026 |